Targeting CD123 in BPDCN: an emerging field.
Sign Up to like & getrecommendations! Published in 2021 at "Expert review of hematology"
DOI: 10.1080/17474086.2021.1988848
Abstract: INTRODUCTION : Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy with historically poor outcomes for patients, often refractory to traditional chemotherapy. Recent research has focused on targeted therapy to improve… read more here.
Keywords: emerging field; bpdcn emerging; treatment; targeting cd123 ... See more keywords